Intellia Therapeutics, Inc.
NTLA
$9.06
$0.9611.85%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.18% | -8.75% | -16.25% | -8.60% | -4.77% |
| Total Receivables | -2.67% | 8.08% | 23.33% | -3.81% | -28.19% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 139.95% | -32.85% | 24.50% | -32.10% | -18.36% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 17.34% | -10.06% | -13.83% | -9.99% | -6.12% |
|
|
|||||
| Total Current Assets | 17.34% | -10.06% | -13.83% | -9.99% | -6.12% |
| Net Property, Plant & Equipment | -8.92% | -6.90% | -33.88% | 91.08% | -4.86% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -69.18% | 24.30% | 150.50% | 3.31% | 0.10% |
| Total Assets | 2.93% | -8.85% | -17.20% | 1.51% | -1.53% |
|
|
|||||
| Total Accounts Payable | 35.28% | -20.72% | -15.25% | 10.99% | -30.14% |
| Total Accrued Expenses | -1.71% | 1.83% | -26.28% | 11.03% | 16.49% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.44% | -30.37% | 91.46% | 5.57% | 1.13% |
| Total Finance Division Other Current Liabilities | -28.61% | -16.97% | 0.00% | -12.10% | -4.11% |
| Total Other Current Liabilities | -28.61% | -16.97% | 0.00% | -12.10% | -4.11% |
| Total Current Liabilities | -1.86% | -15.18% | 1.57% | 4.89% | 0.56% |
|
|
|||||
| Total Current Liabilities | -1.86% | -15.18% | 1.57% | 4.89% | 0.56% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -6.63% | -6.07% | -57.63% | 130.40% | -5.59% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | -4.73% | -27.91% | -19.25% | -19.41% |
| Total Liabilities | -3.70% | -10.96% | -35.36% | 51.40% | -4.42% |
|
|
|||||
| Common Stock & APIC | 4.32% | 1.20% | 0.72% | 1.36% | 4.26% |
| Retained Earnings | -4.23% | -4.42% | -5.25% | -6.29% | -7.09% |
| Treasury Stock & Other | 51.61% | -38.22% | 74.71% | -81.65% | 385.45% |
| Total Common Equity | 4.64% | -8.29% | -10.56% | -9.42% | -0.87% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.64% | -8.29% | -10.56% | -9.42% | -0.87% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.64% | -8.29% | -10.56% | -9.42% | -0.87% |
|
|
|||||